IDHC — Integrated Diagnostics Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Market Cap
$209.28m
Enterprise Value
$219.28m
Revenue
EGP5.72bn

Annual income statement for Integrated Diagnostics Holdings, fiscal year end - December 31st, EGP millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,656	5,225	3,605	4,123	5,720
Cost of Revenue
Gross Profit	1,343	2,804	1,462	1,524	2,182
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,671	2,963	2,773	3,385	4,505
Operating Profit	986	2,262	832	738	1,214
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	969	2,232	854	737	1,440
Provision for Income Taxes
Net Income After Taxes	609	1,493	527	468	1,008
Minority Interest
Net Income Before Extraordinary Items
Net Income	594	1,413	541	510	1,077
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	594	1,413	541	510	1,077
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.99	2.35	0.925	0.901	1.82
Dividends per Share